Osteoclast-targeted treatment of mouse CaPO4-induced aneurysms (TNFα and CaPO4-dependent, RANKL-independent) with bisphosphonate was effective in inhibiting aneurysm formation and TRAP expression [18]. The gene discussed is TNFSF11; the disease is aneurysm.